{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:22:17Z","timestamp":1786123337325,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1213\/ane.0b013e3182918252","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T08:55:07Z","timestamp":1370336107000},"page":"52-60","source":"Crossref","is-referenced-by-count":20,"title":["Mechanism of Autoinduction of Methadone N-Demethylation in Human Hepatocytes"],"prefix":"10.1213","volume":"117","author":[{"given":"Scott D.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Crafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan D.","family":"Kharasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210902","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-010-0793-6","article-title":"The pharmacological treatment of opioid addiction-a clinical perspective.","volume":"66","author":"Lobmaier","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"R5-9-20210902","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone-metabolism, pharmacokinetics and interactions.","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"R6-9-20210902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00952990.2010.540279","article-title":"Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence.","volume":"37","author":"Saber-Tehrani","year":"2011","journal-title":"Am J Drug Alcohol Abuse"},{"key":"R8-9-20210902","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jbi.2006.10.004","article-title":"Surveillance of methadone-related adverse drug events using multiple public health data sources.","volume":"40","author":"Sims","year":"2007","journal-title":"J Biomed Inform"},{"key":"R10-9-20210902","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/PAF.0b013e3181e8af3d","article-title":"The methadone epidemic: methadone-related deaths on the rise in Vermont.","volume":"32","author":"Madden","year":"2011","journal-title":"Am J Forensic Med Pathol"},{"key":"R11-9-20210902","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1360-0443.2000.951778.x","article-title":"Deaths in methadone maintenance treatment in New South Wales, Australia 1990-1995.","volume":"95","author":"Zador","year":"2000","journal-title":"Addiction"},{"key":"R12-9-20210902","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1360-0443.2002.00179.x","article-title":"An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam.","volume":"97","author":"Buster","year":"2002","journal-title":"Addiction"},{"key":"R13-9-20210902","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09595230701373834","article-title":"Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.","volume":"26","author":"Gibson","year":"2007","journal-title":"Drug Alcohol Rev"},{"key":"R14-9-20210902","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0889-8588(02)00017-5","article-title":"The use of methadone for cancer pain.","volume":"16","author":"Ripamonti","year":"2002","journal-title":"Hematol Oncol Clin North Am"},{"key":"R15-9-20210902","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1975173258","article-title":"Disposition of methadone in methadone maintenance.","volume":"17","author":"Anggard","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"R16-9-20210902","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cpt1975182180","article-title":"Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment.","volume":"18","author":"Verebely","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"R17-9-20210902","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00644967","article-title":"Pharmacokinetics of methadone during maintenance therapy: pulse labeling with deuterated methadone in the steady state.","volume":"16","author":"Anggard","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"R18-9-20210902","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cpt1978232175","article-title":"Methadone maintenance: plasma levels and therapeutic outcome.","volume":"23","author":"Holmstrand","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"R19-9-20210902","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-3565(25)29508-8","article-title":"Physiological disposition and metabolism of levo-methadone-1-3 H in nontolerant and tolerant rats.","volume":"185","author":"Misra","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"R20-9-20210902","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/0024-3205(74)90265-3","article-title":"Effect of oral administration of methadone on hepatic microsomal mixed function oxidase activity in mice.","volume":"14","author":"Masten","year":"1974","journal-title":"Life Sci"},{"key":"R21-9-20210902","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1016\/0006-2952(79)90604-X","article-title":"Effect of the route of administration on microsomal enzyme induction following repeated administration of methadone in the mouse.","volume":"28","author":"Kapeghian","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"R22-9-20210902","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.","volume":"16","author":"Gerber","year":"2004","journal-title":"Chirality"},{"key":"R23-9-20210902","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone.","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R24-9-20210902","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric metabolic interactions and stereoselective human methadone metabolism.","volume":"321","author":"Totah","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R25-9-20210902","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism.","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"R26-9-20210902","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1742-7843.2010.00628.x","article-title":"Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.","volume":"108","author":"Chang","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R27-9-20210902","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"R28-9-20210902","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"R29-9-20210902","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"R30-9-20210902","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11904-010-0048-2","article-title":"Methadone, buprenorphine, and street drug interactions with antiretroviral medications.","volume":"7","author":"Gruber","year":"2010","journal-title":"Curr HIVAIDS Rep"},{"key":"R31-9-20210902","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2008.104","article-title":"Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance.","volume":"84","author":"Kharasch","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R32-9-20210902","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/ALN.0b013e3181986a9a","article-title":"Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavirindinavir.","volume":"110","author":"Kharasch","year":"2009","journal-title":"Anesthesiology"},{"key":"R33-9-20210902","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2008.12.009","article-title":"Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity.","volume":"101","author":"Kharasch","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"R34-9-20210902","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1369-1600.2010.00274.x","article-title":"CYP2B6 and OPRM1 gene variations predict methadone-related deaths.","volume":"16","author":"Bunten","year":"2011","journal-title":"Addict Biol"},{"key":"R35-9-20210902","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/clpt.2011.276","article-title":"Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics.","volume":"91","author":"Kharasch","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"R36-9-20210902","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/ALN.0b013e3182423478","article-title":"Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).","volume":"116","author":"Kharasch","year":"2012","journal-title":"Anesthesiology"},{"key":"R37-9-20210902","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2125.1999.00974.x","article-title":"Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.","volume":"48","author":"Rostami-Hodjegan","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"R38-9-20210902","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1046\/j.1360-0443.2000.951217717.x","article-title":"Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.","volume":"95","author":"Wolff","year":"2000","journal-title":"Addiction"},{"key":"R39-9-20210902","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1124\/dmd.109.027854","article-title":"Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor.","volume":"37","author":"Tolson","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"R40-9-20210902","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/abbi.2001.2499","article-title":"Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity.","volume":"393","author":"Rodriguez-Antona","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"R41-9-20210902","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/187231210792928224","article-title":"A multi-endpoint evaluation of cytochrome P450 1A2, 2B6 and 3A4 induction response in human hepatocyte cultures after treatment with -naphthoflavone, phenobarbital and rifampicin.","volume":"4","author":"Zhang","year":"2010","journal-title":"Drug Metab Lett"},{"key":"R42-9-20210902","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/pmic.201000456","article-title":"Quantitative protein determination for CYP induction via LC-MSMS.","volume":"11","author":"Williamson","year":"2011","journal-title":"Proteomics"},{"key":"R43-9-20210902","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/dmd.109.027029","article-title":"In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective.","volume":"37","author":"Chu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"R44-9-20210902","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0026-895X(24)12054-8","article-title":"Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.","volume":"28","author":"Faucette","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"R45-9-20210902","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1124\/dmd.104.002709","article-title":"Metabolism of alfentanil by cytochrome p4503a (cyp3a) enzymes.","volume":"33","author":"Klees","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"R46-9-20210902","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1124\/dmd.110.033126","article-title":"Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes.","volume":"38","author":"Fahmi","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"R47-9-20210902","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF00548404","article-title":"Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.","volume":"22","author":"Nilsson","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"R48-9-20210902","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0031-6997(24)01372-3","article-title":"Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.","volume":"50","author":"Ito","year":"1998","journal-title":"Pharmacol Rev"},{"key":"R49-9-20210902","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"key":"R50-9-20210902","doi-asserted-by":"crossref","first-page":"15122","DOI":"10.1074\/jbc.M001215200","article-title":"Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.","volume":"275","author":"Moore","year":"2000","journal-title":"J Biol Chem"},{"key":"R51-9-20210902","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.106.112136","article-title":"Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers.","volume":"320","author":"Faucette","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"R52-9-20210902","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/dmd.112.050625","article-title":"Methadone N-Demethylation by the Common CYP2B6 Allelic Variant CYP2B6.6.","volume":"41","author":"Gadel","year":"2013","journal-title":"Drug Metab Dispos"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3182918252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:25:38Z","timestamp":1786112738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201307000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3182918252","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}